By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 227
NEW YORK (Reuters Health) – Allogeneic blood transfusions in patients who undergo coronary artery bypass graft surgery (CABG) substantially increase the patient’s odds of nosocomial infection, hospital readmission…
NEW YORK (Reuters Health) – Lung volume reduction surgery extends survival in patients with advanced emphysema and also improves quality of life, new research confirms. “We found lung…
NEW YORK (Reuters Health) – Patients hospitalized for acute coronary syndrome (ACS) are less likely to survive until discharge if they have a known history of prior atherosclerosis,…
NEW YORK (Reuters Health) – A single question may be all it takes for primary care providers to accurately screen patients who may be drinking too much, new…
NEW YORK (Reuters Health) – Vertebroplasty does not improve the pain or disability associated with osteoporotic spinal fractures, according to the results of two randomized trials appearing in…
NEW YORK (Reuters Health) – The well-known association between poor glycemic control and low HDL cholesterol in patients with type 2 diabetes is independent of obesity and hypertriglyceridemia,…
NEW YORK (Reuters Health) – Use of metformin is associated with a decreased risk of pancreatic cancer in patients with diabetes, new research shows. By contrast, treatment with…
NEW YORK (Reuters Health) – Even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial, according to a report in…
NEW YORK (Reuters Health) – Prehypertensive men who are physically fit are likely to live longer as a result, according to a long-term follow-up study published in the…
NEW YORK (Reuters Health) – In trials of antimuscarinic agents for overactive bladder, the placebo responses tend to be large, statistically significant, and heterogeneous, according to a meta-analysis…
